Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Mkt Cap
Market Capitalization
₹721Cr
Rev Gr TTM
Revenue Growth TTM
64.53%
Peer Comparison
Compare up to 10 companies side by side across valuation, profitability, and growth.

MUKKA
VS
| Quarter | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|
|
Growth YoY Revenue Growth YoY% | | | | 30.2 | -39.0 | -37.1 | -55.0 | -41.4 | 48.6 | -1.0 | 63.9 | 115.6 |
| 376 | 258 | 294 | 498 | 225 | 158 | 140 | 262 | 352 | 156 | 224 | 608 |
Operating Profit Operating ProfitCr |
| 10.6 | 6.0 | 11.4 | 3.6 | 12.5 | 8.2 | 6.4 | 13.6 | 7.6 | 8.5 | 8.5 | 7.0 |
Other Income Other IncomeCr | -2 | 1 | 6 | 8 | 5 | 3 | 4 | 6 | 4 | 2 | 6 | 8 |
Interest Expense Interest ExpenseCr | 7 | 6 | 6 | 6 | 7 | 8 | 9 | 11 | 10 | 11 | 13 | 15 |
Depreciation DepreciationCr | 3 | 3 | 3 | 3 | 3 | 3 | 4 | 4 | 3 | 3 | 4 | 4 |
| 33 | 8 | 35 | 17 | 27 | 6 | 1 | 33 | 20 | 2 | 9 | 35 |
| 11 | 4 | 6 | 5 | -2 | 0 | 0 | 6 | 6 | 1 | 2 | 7 |
|
Growth YoY PAT Growth YoY% | | | | -55.8 | 33.0 | 19.3 | -94.9 | 122.0 | -52.0 | -69.8 | 368.0 | 1.7 |
| 5.2 | 1.6 | 8.6 | 2.3 | 11.4 | 3.0 | 1.0 | 8.8 | 3.7 | 0.9 | 2.8 | 4.2 |
| 1.0 | 0.2 | 1.3 | 0.5 | 1.2 | 0.1 | 0.1 | 0.9 | 0.5 | 0.1 | 0.2 | 0.8 |
| Financial Year | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|
|
| | 34.4 | 9.9 | 27.6 | 52.8 | 17.2 | -27.1 | 44.1 |
| 385 | 525 | 582 | 724 | 1,091 | 1,274 | 912 | 1,341 |
Operating Profit Operating ProfitCr |
| 5.7 | 4.3 | 3.6 | 6.1 | 7.3 | 7.6 | 9.4 | 7.6 |
Other Income Other IncomeCr | 2 | 8 | 10 | 7 | 8 | 19 | 16 | 19 |
Interest Expense Interest ExpenseCr | 4 | 7 | 8 | 10 | 16 | 25 | 37 | 49 |
Depreciation DepreciationCr | 2 | 5 | 8 | 9 | 12 | 12 | 14 | 14 |
| 19 | 20 | 15 | 36 | 66 | 87 | 60 | 66 |
| 5 | 6 | 4 | 10 | 18 | 13 | 12 | 17 |
|
| | -0.8 | -18.9 | 134.5 | 84.1 | 56.4 | -35.3 | 3.4 |
| 3.4 | 2.5 | 1.8 | 3.4 | 4.0 | 5.4 | 4.8 | 3.4 |
| 259.8 | 239.6 | 0.5 | 1.1 | 2.0 | 3.1 | 1.6 | 1.5 |
| Financial Year | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|
Equity Capital Equity CapitalCr | 6 | 6 | 6 | 22 | 22 | 30 | 30 | 30 |
| 38 | 51 | 61 | 76 | 126 | 366 | 411 | 414 |
Current Liabilities Current LiabilitiesCr | 137 | 217 | 272 | 274 | 403 | 521 | 610 | 757 |
Non Current Liabilities Non Current LiabilitiesCr | 20 | 18 | 13 | 15 | 17 | 12 | 9 | 20 |
Total Liabilities Total LiabilitiesCr |
Current Assets Current AssetsCr | 142 | 206 | 257 | 286 | 464 | 817 | 926 | 1,049 |
Non Current Assets Non Current AssetsCr | 59 | 87 | 97 | 106 | 111 | 124 | 151 | 191 |
Total Assets Total AssetsCr |
| Financial Year | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Operating Cash Flow Operating Cash FlowCr | -20 | -25 | 2 | 5 | -56 | -150 | -112 |
Investing Cash Flow Investing Cash FlowCr | -23 | -28 | -14 | -11 | -3 | -48 | -35 |
Financing Cash Flow Financing Cash FlowCr | 34 | 54 | 13 | 15 | 75 | 266 | 56 |
|
Free Cash Flow Free Cash FlowCr | -39 | -61 | -8 | -1 | -64 | -165 | -130 |
| -148.2 | -184.7 | 16.3 | 18.9 | -118.5 | -202.4 | -232.7 |
CFO To EBITDA CFO To EBITDA% | -86.8 | -105.4 | 8.2 | 10.4 | -65.4 | -142.6 | -118.0 |
| Financial Year | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Valuation Ratios Valuation Ratios |
Market Cap Market CapitalizationCr | 0 | 0 | 0 | 0 | 0 | 1,094 | 981 |
Price To Earnings Price To Earnings | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 15.6 | 21.1 |
Price To Sales Price To Sales | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.8 | 1.0 |
Price To Book Price To Book | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 2.8 | 2.2 |
| 3.5 | 5.9 | 7.1 | 3.5 | 2.7 | 12.6 | 14.7 |
Profitability Ratios Profitability Ratios |
| 15.3 | 13.9 | 14.9 | 17.6 | 20.0 | 17.7 | 23.0 |
| 5.7 | 4.3 | 3.6 | 6.1 | 7.3 | 7.6 | 9.4 |
| 3.4 | 2.5 | 1.8 | 3.4 | 4.0 | 5.4 | 4.8 |
| 18.2 | 13.6 | 10.4 | 16.7 | 20.1 | 14.8 | 10.9 |
| 31.1 | 24.0 | 16.6 | 26.3 | 32.1 | 18.8 | 10.9 |
| 6.8 | 4.6 | 3.1 | 6.6 | 8.3 | 7.9 | 4.5 |
Operational Ratios Operational Ratios |
Solvency Ratios Solvency Ratios |
Liquidity Ratios Liquidity Ratios |
Mukka Proteins Limited (**MPL**) is India’s dominant force in the marine protein industry, commanding a **25-30%** market share in the domestic fishmeal and fish oil sector. The company operates an integrated "waste-to-value" ecosystem, converting marine discards and organic waste into high-value nutritional ingredients for global aquaculture, livestock, and industrial markets. Following its **March 2024 IPO**, MPL has pivoted toward a "multi-engine growth" model, diversifying into insect-based biotechnology and large-scale environmental services.
---
### **The "Waste-to-Value" Ecosystem: Core Business Verticals**
MPL’s operations are built on a circular manufacturing model designed to achieve **zero-waste** and **zero-landfill** objectives by monetizing every output of the production process.
#### **1. Marine Protein & Lipids (Core)**
The company processes sustainably sourced pelagic fish (sardines and mackerels) into essential feed ingredients:
* **Fishmeal:** High-protein (**60-65%**, up to **80%**) supplement for aquaculture, poultry, and pet food.
* **Fish Oil:** Rich in **Omega-3 (EPA & DHA)**; used in aquafeed, pharmaceuticals, and veterinary products.
* **Fish Soluble Paste:** A nutrient-dense liquid additive that enhances feed palatability, particularly in shrimp farming.
* **Frozen & Value-Added:** Forward integration into **Surimi** (capacity: **~5,000 MT p.a.**) and **IQF Frozen Seafood** (shrimp, squid, mackerel) with a freezing capacity of **50 MT per day**.
#### **2. Insect Biotech Platform (Alternative Protein)**
Through its subsidiary **Ento Proteins**, MPL is a pioneer in commercializing **Black Soldier Fly (BSF)** technology. This vertical upcycles municipal wet waste into sustainable protein:
* **Insect Meal & Oil:** Highly digestible, antimicrobial fishmeal substitutes for animal nutrition.
* **Organic Inputs:** Production of **Insect Compost**, **Humic Acid**, and **Bio-stimulants** for the horticulture and organic farming sectors.
* **Briquettes:** Sustainable fuel generated from BSF waste residues.
#### **3. Environmental Services & Carbon Credits**
MPL has leveraged its organic processing expertise to enter the high-margin environmental sector:
* **Leachate Treatment:** Secured a landmark **₹474.89 crore** order from **Bengaluru Solid Waste Management Limited** for the scientific treatment of legacy leachate over **4 years** (JV stake: **76%**).
* **Carbon Credits:** Formally listed **300 TPD** wet waste operations on the **Verra Registry** (Project ID 5893), with approvals to expand to **1,000 TPD** for **Verified Carbon Unit (VCU)** generation.
---
### **Manufacturing Footprint & Global Supply Chain**
MPL maintains a geographically diversified production footprint to ensure proximity to raw material hubs and international ports.
| Facility Type | Count / Capacity | Strategic Advantage |
| :--- | :--- | :--- |
| **Total Installed Capacity** | **2,64,390 MT** per year | Largest in India for Fishmeal/Oil |
| **Owned Production Units** | **16** | Located in India and **Oman** |
| **Total Manufacturing Units** | **24** | Includes owned, 3rd party, and job work |
| **Blending & Storage** | **4 / 14** | Strategic West Coast India presence |
| **Export Reach** | **25+ Countries** | **75.7%** of revenue from exports (**9MFY26**) |
**Key Certifications:** MPL is one of the few Indian companies licensed by **AQSIQ** (China) and holds **MarinTrust**, **GMP+**, **ISO 22000**, and **HACCP** certifications.
---
### **Strategic Growth & Inorganic Expansion**
Since its listing, MPL has pursued aggressive consolidation to achieve **100% ownership** of key subsidiaries and expand its international manufacturing base.
* **Consolidation:** Increased stakes in **Ento Proteins** (to **100%**), **Haris Marine Products** (to **100%**), and **Ocean Proteins** (to **51%**).
* **Capacity Expansion:** Acquired **51%** in **GSM Marine Export** (**₹14 crore**) and **FABBCO** (**₹5.95 crore**) to scale fishmeal and BSF projects.
* **International Expansion:** Operates **Ocean Aquatic Proteins LLC** in **Oman** (63% subsidiary) and is finalizing a **70%** stake in **Mukka Proteins Vietnam Co., Ltd** (target: **June 2026**).
* **Capital Structure:** Increased authorized share capital to **₹40 crore** and executed a preferential issue at **₹50/share** in **February 2025** to fund expansion.
---
### **Financial Performance & Credit Profile**
While MPL has shown strong historical growth, recent years have been marked by volatility and working capital stress.
| Metric (₹ Crore) | FY25 (Actual) | FY24 (Actual) | FY23 (Actual) |
| :--- | :--- | :--- | :--- |
| **Revenue from Operations** | **1,006.41** | **1,379.83** | **1,177.12** |
| **Profit After Tax (PAT)** | **48.09** | **74.30** | **47.53** |
| **PBILDT Margin** | **10.15%** | **8.25%** | - |
| **Net Debt to Equity** | **92.96%** | **55.95%** | **172.34%** |
| **Inventory Days** | **210** | **97** | - |
**Credit Outlook:** In early **2026**, **CARE Ratings** downgraded the company to **CARE BBB; Negative**. This reflects a **27.06%** revenue contraction in **FY25** and an elongated operating cycle of **226 days**. However, **H1 FY26** showed a recovery with **28% YoY** revenue growth (**₹415 crore**) as global fishmeal prices trended upward.
---
### **Risk Matrix & Mitigation**
#### **Operational & Market Risks**
* **Seasonality:** Business is highly dependent on fishing bans and climatic changes. Raw material costs exceed **80%** of sales.
* **Working Capital:** Operations are capital-intensive; net cash flow from operations was **negative ₹107 crore** in **FY25**.
* **Concentration:** The **top 2 customers** account for **40.97%** of revenue.
* **Regulatory Barriers:** **MPEDA** has a moratorium on new export registrations for fishmeal, creating high entry barriers but also limiting MPL's own expansion flexibility.
#### **Legal & Contingent Liabilities**
MPL is currently contesting several tax and regulatory demands:
* **Customs:** **₹7.67 crore** regarding Export Obligation Discharge Certificates.
* **GST/CGST:** **₹4.37 crore** (IPO expense ITC) and **₹9.82 crore** (Fish Soluble Paste classification).
* **Income Tax:** Demands totaling **~₹17 crore** across multiple assessment years following search and seizure actions.
#### **Financial Risks**
* **Interest Rate Volatility:** Variable rate borrowings increased to **₹355.87 crore** in **2024**.
* **Forex:** The company hedges **~50%** of its foreign exchange exposure via forward contracts.